Letters

Neurosurgery Responds to CY 2026 Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposals

  • Quality Improvement and Patient Safety
  • Reimbursement and Practice Management

Jeff Wu
Acting Administrator
Centers for Medicare & Medicaid Services
7500 Security Boulevard
Baltimore, MD 21244-1850

Re: CY 2026 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug
Benefit Programs Proposed Rule (CMS-4192-P)

Dear Acting Administrator Wu:

The Alliance of Specialty Medicine (the “Alliance”), representing more than 100,000 specialty physicians from sixteen specialty and subspecialty societies, is deeply committed to improving access to specialty medical care by advancing sound health policy. On behalf of the undersigned members, we write to provide feedback on proposed policy changes for Medicare Advantage (MA) and Part D prescription drug plans and their impact on access to specialty medical care.

Read full letter here.